Skip to content

Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study)

Clinical Concordance Evaluation of the T-SPOT®.TB Assay Performance Using Positive Selection With the T-Cell SelectTM Kit and Density Gradient Cell Isolation Methods

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04141982
Enrollment
680
Registered
2019-10-28
Start date
2019-11-04
Completion date
2020-03-18
Last updated
2022-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Brief summary

The objective is to achieve 90% overall, positive and negative clinical concordance between results of the T-SPOT.TB assay, using cells isolated via density gradient centrifugation and positive selection using the T-Cell Select kit, between 0-55 hours following venepuncture

Detailed description

In this study, clinical concordance between results of the T-SPOT.TB assay, using cells stored for 0-8 hours post venepuncture and isolated via density gradient separation and positive selection with magnetic bead isolation using the T-Cell SelectTM Kit will be assessed. Concordance between results of the T-SPOT.TB assay at 0-8 hours post venepuncture and using cells isolated with density gradient centrifugation and results obtained from cells isolated using the T-Cell Select Kit, following storage between 0-55 hours post venepuncture, will be assessed.

Interventions

DIAGNOSTIC_TESTT-Cell SelectTM Kit

The T-Cell Select kit is intended for the isolation of mononuclear immune cells from whole blood, using positive selection via a magnetic bead-based cell separation system, for use in the T-SPOT.TB assay.

Sponsors

Oxford Immunotec
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Subjects presenting at sites enrolling suspected of having TB infection population Inclusion Criteria * Be able to provide informed consent * Be able to provide a minimum of 7 mL and maximum of 20 mL of whole blood. * Have suspected TB infection. * Be at least 18 years of age. * Live in a high endemic area for TB infection

Exclusion criteria

• Unable to meet inclusion criteria Subjects presenting at sites enrolling no (or minimal) TB risk factors population Inclusion Criteria * Be able to provide informed consent * Be able to provide a minimum of 7 mL and maximum of 20 mL of whole blood. * Have no suspicion TB infection. * Be at least 18 years of age. * Live in low endemic area for TB infection * Have no previous medical record of TB infection

Design outcomes

Primary

MeasureTime frameDescription
Achieving positive and negative clinical concordance between results of the T-SPOT.TB assay between 0-55hours after venipuncture1 yearAchieving 90% overall, positive and negative clinical concordance between results of the T-SPOT.TB assay, using cells isolated via density gradient centrifugation and positive selection using the T-Cell Select kit, between 0-55 hours following venepuncture

Countries

South Africa, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026